Header Logo

Connection

David Bennett to Cognition Disorders

Back to Details
This is a "connection" page, showing publications David Bennett has written about Cognition Disorders.
David Bennett
Connection Strength
25.512
Cognition Disorders
  1. Selective serotonin reuptake inhibitor use, age-related neuropathology and cognition in late-life. Psychiatry Res. 2023 10; 328:115471.
    View in: PubMed
    Score: 0.532
  2. Modifiable psychosocial risk factors and delayed onset of dementia in older populations: analysis of two prospective US cohorts. BMJ Open. 2022 04 04; 12(4):e059317.
    View in: PubMed
    Score: 0.482
  3. The Relation of Diabetes to Memory Function. Curr Neurol Neurosci Rep. 2020 11 05; 20(12):64.
    View in: PubMed
    Score: 0.437
  4. Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline. Alzheimers Dement. 2017 Dec; 13(12):1380-1388.
    View in: PubMed
    Score: 0.345
  5. Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline. Brain. 2017 03 01; 140(3):804-812.
    View in: PubMed
    Score: 0.338
  6. Higher brain BDNF gene expression is associated with slower cognitive decline in older adults. Neurology. 2016 Feb 23; 86(8):735-41.
    View in: PubMed
    Score: 0.314
  7. Change in Cognitive Abilities in Older Latinos. J Int Neuropsychol Soc. 2016 Jan; 22(1):58-65.
    View in: PubMed
    Score: 0.309
  8. Author response. Neurology. 2015 Jul 28; 85(4):389.
    View in: PubMed
    Score: 0.303
  9. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging. 2015 Jul; 36(7):2225-2231.
    View in: PubMed
    Score: 0.297
  10. Conscientiousness, dementia related pathology, and trajectories of cognitive aging. Psychol Aging. 2015 Mar; 30(1):74-82.
    View in: PubMed
    Score: 0.293
  11. Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology. 2015 May; 29(3):335-43.
    View in: PubMed
    Score: 0.290
  12. Brain pathology contributes to simultaneous change in physical frailty and cognition in old age. J Gerontol A Biol Sci Med Sci. 2014 Dec; 69(12):1536-44.
    View in: PubMed
    Score: 0.284
  13. Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology. 2014 Aug 19; 83(8):702-9.
    View in: PubMed
    Score: 0.283
  14. Cognitive and social lifestyle: links with neuropathology and cognition in late life. Acta Neuropathol. 2014 Jan; 127(1):137-50.
    View in: PubMed
    Score: 0.271
  15. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014 Apr; 35(4):819-26.
    View in: PubMed
    Score: 0.267
  16. Cognitive frailty. J Nutr Health Aging. 2013 Sep; 17(9):738-9.
    View in: PubMed
    Score: 0.266
  17. Cognitive decline impairs financial and health literacy among community-based older persons without dementia. Psychol Aging. 2013 Sep; 28(3):614-24.
    View in: PubMed
    Score: 0.265
  18. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol. 2013 Sep; 74(3):478-89.
    View in: PubMed
    Score: 0.263
  19. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013 Jul 23; 81(4):314-21.
    View in: PubMed
    Score: 0.263
  20. APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
    View in: PubMed
    Score: 0.260
  21. Neural reserve, neuronal density in the locus ceruleus, and cognitive decline. Neurology. 2013 Mar 26; 80(13):1202-8.
    View in: PubMed
    Score: 0.257
  22. The influence of cognitive decline on well-being in old age. Psychol Aging. 2013 Jun; 28(2):304-13.
    View in: PubMed
    Score: 0.256
  23. Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2013; 33 Suppl 1:S397-403.
    View in: PubMed
    Score: 0.254
  24. Neuroticism modifies the association of vision impairment and cognition among community-dwelling older adults. Neuroepidemiology. 2013; 40(2):142-6.
    View in: PubMed
    Score: 0.252
  25. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
    View in: PubMed
    Score: 0.249
  26. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol. 2012 Oct; 72(4):599-609.
    View in: PubMed
    Score: 0.249
  27. Poor decision making is a consequence of cognitive decline among older persons without Alzheimer's disease or mild cognitive impairment. PLoS One. 2012; 7(8):e43647.
    View in: PubMed
    Score: 0.247
  28. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging. 2013 Jan; 34(1):157-68.
    View in: PubMed
    Score: 0.242
  29. Effect of purpose in life on the relation between Alzheimer disease pathologic changes on cognitive function in advanced age. Arch Gen Psychiatry. 2012 May; 69(5):499-505.
    View in: PubMed
    Score: 0.242
  30. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology. 2012 Apr 24; 78(17):1323-9.
    View in: PubMed
    Score: 0.241
  31. Terminal dedifferentiation of cognitive abilities. Neurology. 2012 Apr 10; 78(15):1116-22.
    View in: PubMed
    Score: 0.241
  32. Life space and risk of Alzheimer disease, mild cognitive impairment, and cognitive decline in old age. Am J Geriatr Psychiatry. 2011 Nov; 19(11):961-9.
    View in: PubMed
    Score: 0.234
  33. Late-life social activity and cognitive decline in old age. J Int Neuropsychol Soc. 2011 Nov; 17(6):998-1005.
    View in: PubMed
    Score: 0.234
  34. Vulnerability to stress, anxiety, and development of dementia in old age. Am J Geriatr Psychiatry. 2011 Apr; 19(4):327-34.
    View in: PubMed
    Score: 0.225
  35. Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol. 2011 Mar; 68(3):351-6.
    View in: PubMed
    Score: 0.223
  36. Neurodegenerative basis of age-related cognitive decline. Neurology. 2010 Sep 21; 75(12):1070-8.
    View in: PubMed
    Score: 0.216
  37. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2010 May 18; 74(20):1656; author reply 1656-7.
    View in: PubMed
    Score: 0.211
  38. Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons. Arch Gen Psychiatry. 2010 Mar; 67(3):304-10.
    View in: PubMed
    Score: 0.208
  39. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J Am Geriatr Soc. 2010 Feb; 58(2):248-55.
    View in: PubMed
    Score: 0.206
  40. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons. Neuroepidemiology. 2010; 34(1):43-9.
    View in: PubMed
    Score: 0.204
  41. Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch Neurol. 2009 Nov; 66(11):1339-44.
    View in: PubMed
    Score: 0.204
  42. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2009 Sep 22; 73(12):920-7.
    View in: PubMed
    Score: 0.200
  43. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009 Aug; 66(2):200-8.
    View in: PubMed
    Score: 0.200
  44. Relation of hemoglobin to level of cognitive function in older persons. Neuroepidemiology. 2009; 32(1):40-6.
    View in: PubMed
    Score: 0.190
  45. Plaque complement activation and cognitive loss in Alzheimer's disease. J Neuroinflammation. 2008 Mar 11; 5:9.
    View in: PubMed
    Score: 0.182
  46. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology. 2008 May 06; 70(19 Pt 2):1795-802.
    View in: PubMed
    Score: 0.180
  47. Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment. Arch Gen Psychiatry. 2007 Oct; 64(10):1204-12.
    View in: PubMed
    Score: 0.176
  48. Lower extremity motor function and disability in mild cognitive impairment. Exp Aging Res. 2007 Jul-Sep; 33(3):355-71.
    View in: PubMed
    Score: 0.173
  49. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry. 2007 Jul; 64(7):802-8.
    View in: PubMed
    Score: 0.173
  50. Chronic distress and incidence of mild cognitive impairment. Neurology. 2007 Jun 12; 68(24):2085-92.
    View in: PubMed
    Score: 0.173
  51. Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. Psychosom Med. 2007 Jun; 69(5):483-9.
    View in: PubMed
    Score: 0.172
  52. Terminal cognitive decline: accelerated loss of cognition in the last years of life. Psychosom Med. 2007 Feb-Mar; 69(2):131-7.
    View in: PubMed
    Score: 0.168
  53. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol. 2006 Dec; 63(12):1763-9.
    View in: PubMed
    Score: 0.166
  54. Cognitive decline in old age: separating retest effects from the effects of growing older. Psychol Aging. 2006 Dec; 21(4):774-89.
    View in: PubMed
    Score: 0.166
  55. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline. Neurology. 2006 Aug 08; 67(3):441-5.
    View in: PubMed
    Score: 0.163
  56. Reno-cerebrovascular disease? The incognito kidney in cognition and stroke. Neurology. 2006 Jul 25; 67(2):196-8.
    View in: PubMed
    Score: 0.162
  57. Diabetes mellitus, dementia, and cognitive function in older persons. J Nutr Health Aging. 2006 Jul-Aug; 10(4):287-91.
    View in: PubMed
    Score: 0.162
  58. Postmortem indices linking risk factors to cognition: results from the Religious Order Study and the Memory and Aging Project. Alzheimer Dis Assoc Disord. 2006 Jul-Sep; 20(3 Suppl 2):S63-8.
    View in: PubMed
    Score: 0.162
  59. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006 Jun 27; 66(12):1837-44.
    View in: PubMed
    Score: 0.161
  60. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol. 2006 May; 5(5):406-12.
    View in: PubMed
    Score: 0.160
  61. Parkinsonian signs in subjects with mild cognitive impairment. Neurology. 2005 Dec 27; 65(12):1901-6.
    View in: PubMed
    Score: 0.156
  62. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology. 2006; 26(2):61-7.
    View in: PubMed
    Score: 0.156
  63. Mild cognitive impairment in different functional domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov; 76(11):1479-84.
    View in: PubMed
    Score: 0.154
  64. Education modifies the association of amyloid but not tangles with cognitive function. Neurology. 2005 Sep 27; 65(6):953-5.
    View in: PubMed
    Score: 0.153
  65. Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people. J Neurol Neurosurg Psychiatry. 2005 Sep; 76(9):1194-9.
    View in: PubMed
    Score: 0.153
  66. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005 Jun; 62(6):685-91.
    View in: PubMed
    Score: 0.150
  67. Mild cognitive impairment: is it Alzheimer's disease or not? J Alzheimers Dis. 2005 Jun; 7(3):241-5; discussion 255-62.
    View in: PubMed
    Score: 0.150
  68. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005 Mar 08; 64(5):834-41.
    View in: PubMed
    Score: 0.147
  69. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment. Neurocase. 2005 Feb; 11(1):3-7.
    View in: PubMed
    Score: 0.147
  70. Assessment of cognitive decline in old age with brief tests amenable to telephone administration. Neuroepidemiology. 2005; 25(1):19-25.
    View in: PubMed
    Score: 0.146
  71. Relationship between Alzheimer's disease clinical stage and Gq/11 in subcellular fractions of frontal cortex. J Neural Transm (Vienna). 2005 Aug; 112(8):1049-56.
    View in: PubMed
    Score: 0.145
  72. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004 May; 61(5):661-6.
    View in: PubMed
    Score: 0.139
  73. Cerebral infarctions and the relationship of depression symptoms to level of cognitive functioning in older persons. Am J Geriatr Psychiatry. 2004 Mar-Apr; 12(2):211-9.
    View in: PubMed
    Score: 0.137
  74. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol. 2004 Mar; 61(3):378-84.
    View in: PubMed
    Score: 0.137
  75. Mild cognitive impairment. Clin Geriatr Med. 2004 Feb; 20(1):15-25.
    View in: PubMed
    Score: 0.137
  76. Update on mild cognitive impairment. Curr Neurol Neurosci Rep. 2003 Sep; 3(5):379-84.
    View in: PubMed
    Score: 0.133
  77. Association of Motor Function With Cognitive Trajectories and Structural Brain Differences: A Community-Based Cohort Study. Neurology. 2023 10 24; 101(17):e1718-e1728.
    View in: PubMed
    Score: 0.133
  78. Gender, cognitive decline, and risk of AD in older persons. Neurology. 2003 Jun 10; 60(11):1777-81.
    View in: PubMed
    Score: 0.131
  79. Terminal decline in cognitive function. Neurology. 2003 Jun 10; 60(11):1782-7.
    View in: PubMed
    Score: 0.131
  80. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology. 2003 Apr 08; 60(7):1082-8.
    View in: PubMed
    Score: 0.129
  81. The association of MIND diet with cognitive resilience to neuropathologies. Alzheimers Dement. 2023 08; 19(8):3644-3653.
    View in: PubMed
    Score: 0.128
  82. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002 Aug 13; 59(3):364-70.
    View in: PubMed
    Score: 0.123
  83. Cognitive domain harmonization and cocalibration in studies of older adults. Neuropsychology. 2023 May; 37(4):409-423.
    View in: PubMed
    Score: 0.123
  84. Natural history of mild cognitive impairment in older persons. Neurology. 2002 Jul 23; 59(2):198-205.
    View in: PubMed
    Score: 0.123
  85. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging. 2002 Jun; 17(2):179-93.
    View in: PubMed
    Score: 0.122
  86. Frequency of Parkinsonism and Parkinson Disease in African Americans in the Chicago Community. J Gerontol A Biol Sci Med Sci. 2021 06 14; 76(7):1340-1345.
    View in: PubMed
    Score: 0.114
  87. Risk factors for the progression of motoric cognitive risk syndrome to dementia: Retrospective cohort analysis of two populations. Eur J Neurol. 2021 06; 28(6):1859-1867.
    View in: PubMed
    Score: 0.113
  88. Neuropathologic burden and the degree of frailty in relation to global cognition and dementia. Neurology. 2020 12 15; 95(24):e3269-e3279.
    View in: PubMed
    Score: 0.108
  89. Peripheral serum metabolomic profiles inform central cognitive impairment. Sci Rep. 2020 08 20; 10(1):14059.
    View in: PubMed
    Score: 0.108
  90. Associations Between Cardiovascular Risk, Structural Brain Changes, and Cognitive Decline. J Am Coll Cardiol. 2020 05 26; 75(20):2525-2534.
    View in: PubMed
    Score: 0.106
  91. Differences in the Associations Between Memory Complaints and Depressive Symptoms Among Black and White Older Adults. J Gerontol B Psychol Sci Soc Sci. 2020 03 09; 75(4):783-791.
    View in: PubMed
    Score: 0.104
  92. Proportion of cognitive loss attributable to terminal decline. Neurology. 2020 01 07; 94(1):e42-e50.
    View in: PubMed
    Score: 0.102
  93. A Multi-study Coordinated Meta-analysis of Pulmonary Function and Cognition in Aging. J Gerontol A Biol Sci Med Sci. 2019 10 04; 74(11):1793-1804.
    View in: PubMed
    Score: 0.101
  94. Interaction between the progression of Alzheimer's disease and fractal degradation. Neurobiol Aging. 2019 11; 83:21-30.
    View in: PubMed
    Score: 0.101
  95. Motoric cognitive risk syndrome and predictors of transition to dementia: A multicenter study. Alzheimers Dement. 2019 07; 15(7):870-877.
    View in: PubMed
    Score: 0.099
  96. Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons. J Affect Disord. 2019 05 01; 250:313-318.
    View in: PubMed
    Score: 0.097
  97. Quantitative Assessment of Pathological Tau Burden in Essential Tremor: A Postmortem Study. J Neuropathol Exp Neurol. 2019 01 01; 78(1):31-37.
    View in: PubMed
    Score: 0.096
  98. Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol. 2018 07; 84(1):78-88.
    View in: PubMed
    Score: 0.093
  99. Fractal regulation and incident Alzheimer's disease in elderly individuals. Alzheimers Dement. 2018 09; 14(9):1114-1125.
    View in: PubMed
    Score: 0.092
  100. Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol. 2018 04; 83(4):718-729.
    View in: PubMed
    Score: 0.091
  101. A? mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease. J Neurosci. 2018 01 31; 38(5):1085-1099.
    View in: PubMed
    Score: 0.089
  102. Are latent variable models preferable to composite score approaches when assessing risk factors of change? Evaluation of type-I error and statistical power in longitudinal cognitive studies. Stat Methods Med Res. 2019 07; 28(7):1942-1957.
    View in: PubMed
    Score: 0.089
  103. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med. 2017 04; 14(4):e1002287.
    View in: PubMed
    Score: 0.085
  104. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease. Acta Neuropathol. 2017 03; 133(3):395-407.
    View in: PubMed
    Score: 0.083
  105. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016 08; 15(9):934-943.
    View in: PubMed
    Score: 0.081
  106. Cognitive activity, cognitive function, and brain diffusion characteristics in old age. Brain Imaging Behav. 2016 06; 10(2):455-63.
    View in: PubMed
    Score: 0.080
  107. Grey matter correlates of susceptibility to scams in community-dwelling older adults. Brain Imaging Behav. 2016 06; 10(2):524-32.
    View in: PubMed
    Score: 0.080
  108. Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease. Alzheimers Dement. 2016 06; 12(6):645-53.
    View in: PubMed
    Score: 0.080
  109. Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease. Mol Psychiatry. 2017 02; 22(2):287-295.
    View in: PubMed
    Score: 0.079
  110. Independent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United States. Psychol Aging. 2016 05; 31(3):262-73.
    View in: PubMed
    Score: 0.079
  111. Late-life depression is not associated with dementia-related pathology. Neuropsychology. 2016 Feb; 30(2):135-42.
    View in: PubMed
    Score: 0.078
  112. Regional Neocortical Gray Matter Structure and Sleep Fragmentation in Older Adults. Sleep. 2016 Jan 01; 39(1):227-35.
    View in: PubMed
    Score: 0.078
  113. Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol Neurodegener. 2015 Dec 02; 10:65.
    View in: PubMed
    Score: 0.078
  114. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015 Dec 01; 85(22):1930-6.
    View in: PubMed
    Score: 0.077
  115. Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology. 2015 Sep 15; 85(11):984-91.
    View in: PubMed
    Score: 0.076
  116. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015 Sep; 11(9):1015-22.
    View in: PubMed
    Score: 0.075
  117. Cognitive aging in older Black and White persons. Psychol Aging. 2015 Jun; 30(2):279-85.
    View in: PubMed
    Score: 0.075
  118. A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol. 2015 Mar; 77(3):469-77.
    View in: PubMed
    Score: 0.074
  119. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949). Mol Psychiatry. 2015 Feb; 20(2):183-92.
    View in: PubMed
    Score: 0.073
  120. Motoric cognitive risk syndrome: Multicenter incidence study. Neurology. 2014 Dec 09; 83(24):2278-84.
    View in: PubMed
    Score: 0.072
  121. Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons. Neurology. 2014 Oct 14; 83(16):1410-6.
    View in: PubMed
    Score: 0.071
  122. Motoric cognitive risk syndrome: multicountry prevalence and dementia risk. Neurology. 2014 Aug 19; 83(8):718-26.
    View in: PubMed
    Score: 0.071
  123. An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease. Alzheimers Dement. 2014 Nov; 10(6):666-74.
    View in: PubMed
    Score: 0.069
  124. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2014 Jan 21; 82(3):222-9.
    View in: PubMed
    Score: 0.068
  125. Modification of the relationship of the apolipoprotein E e4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 2013 Dec; 70(12):1544-51.
    View in: PubMed
    Score: 0.068
  126. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 2013 Nov; 70(11):1418-24.
    View in: PubMed
    Score: 0.067
  127. Cognitive decline in older persons initiating anticholinergic medications. PLoS One. 2013; 8(5):e64111.
    View in: PubMed
    Score: 0.065
  128. Genome-wide association study of the rate of cognitive decline in Alzheimer's disease. Alzheimers Dement. 2014 Jan; 10(1):45-52.
    View in: PubMed
    Score: 0.064
  129. Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology. 2013; 40(2):73-84.
    View in: PubMed
    Score: 0.063
  130. Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res. 2012 Jul; 9(6):646-63.
    View in: PubMed
    Score: 0.061
  131. Perceived discrimination and cognition in older African Americans. J Int Neuropsychol Soc. 2012 Sep; 18(5):856-65.
    View in: PubMed
    Score: 0.061
  132. Increased fragmentation of rest-activity patterns is associated with a characteristic pattern of cognitive impairment in older individuals. Sleep. 2012 May 01; 35(5):633-40B.
    View in: PubMed
    Score: 0.061
  133. Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet. 2012 Apr 15; 44(5):545-51.
    View in: PubMed
    Score: 0.060
  134. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012 Apr; 122(4):1316-38.
    View in: PubMed
    Score: 0.060
  135. A coding variant in CR1 interacts with APOE-e4 to influence cognitive decline. Hum Mol Genet. 2012 May 15; 21(10):2377-88.
    View in: PubMed
    Score: 0.060
  136. A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging. 2012 May; 33(5):1017.e1-15.
    View in: PubMed
    Score: 0.058
  137. Cognitive function is associated with risk aversion in community-based older persons. BMC Geriatr. 2011 Sep 11; 11:53.
    View in: PubMed
    Score: 0.058
  138. Cognitive decline in the elderly: an analysis of population heterogeneity. Age Ageing. 2011 Nov; 40(6):684-9.
    View in: PubMed
    Score: 0.058
  139. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. 2011 Sep; 70(9):788-98.
    View in: PubMed
    Score: 0.058
  140. ELISA measurement of specific non-antigen-bound antibodies to A?1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects. J Neuroinflammation. 2011 Aug 09; 8:93.
    View in: PubMed
    Score: 0.058
  141. A life course model of cognitive activities, socioeconomic status, education, reading ability, and cognition. J Am Geriatr Soc. 2011 Aug; 59(8):1403-11.
    View in: PubMed
    Score: 0.057
  142. Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis. Neurology. 2011 Jul 19; 77(3):219-26.
    View in: PubMed
    Score: 0.057
  143. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging. 2012 Aug; 33(8):1599-608.
    View in: PubMed
    Score: 0.057
  144. Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project. Curr Alzheimer Res. 2011 Jun; 8(4):336-40.
    View in: PubMed
    Score: 0.057
  145. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May; 7(3):280-92.
    View in: PubMed
    Score: 0.056
  146. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
    View in: PubMed
    Score: 0.056
  147. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011 Mar; 42(3):722-7.
    View in: PubMed
    Score: 0.055
  148. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011 Feb; 69(2):320-7.
    View in: PubMed
    Score: 0.055
  149. Loss of basic lexical knowledge in old age. J Neurol Neurosurg Psychiatry. 2011 Apr; 82(4):369-72.
    View in: PubMed
    Score: 0.054
  150. Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Arch Neurol. 2010 Jul; 67(7):855-61.
    View in: PubMed
    Score: 0.053
  151. The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol. 2010 Apr; 67(4):475-82.
    View in: PubMed
    Score: 0.052
  152. Diabetes and cognitive systems in older black and white persons. Alzheimer Dis Assoc Disord. 2010 Jan-Mar; 24(1):37-42.
    View in: PubMed
    Score: 0.051
  153. A battery of tests for assessing cognitive function in older Latino persons. Alzheimer Dis Assoc Disord. 2009 Oct-Dec; 23(4):384-8.
    View in: PubMed
    Score: 0.051
  154. Olfactory impairment in presymptomatic Alzheimer's disease. Ann N Y Acad Sci. 2009 Jul; 1170:730-5.
    View in: PubMed
    Score: 0.050
  155. Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J Neurochem. 2009 Aug; 110(4):1241-53.
    View in: PubMed
    Score: 0.050
  156. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.049
  157. Repetition priming and change in functional ability in older persons without dementia. Neuropsychology. 2009 Jan; 23(1):98-104.
    View in: PubMed
    Score: 0.048
  158. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis. 2009; 18(3):691-701.
    View in: PubMed
    Score: 0.048
  159. Cognitive health in indigenous peoples. Neurology. 2008 Nov 04; 71(19):1466-7.
    View in: PubMed
    Score: 0.047
  160. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology. 2008 Jun 03; 70(23):2219-25.
    View in: PubMed
    Score: 0.046
  161. Anti-inflammatory agents and cognitive decline in a bi-racial population. Neuroepidemiology. 2008; 30(1):45-50.
    View in: PubMed
    Score: 0.045
  162. Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology. J Alzheimers Dis. 2008 Feb; 13(1):53-66.
    View in: PubMed
    Score: 0.045
  163. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2007 Dec; 12(4):377-90.
    View in: PubMed
    Score: 0.045
  164. Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J Neurosci. 2007 Oct 03; 27(40):10810-7.
    View in: PubMed
    Score: 0.044
  165. Mild Parkinsonian signs: An overview of an emerging concept. Mov Disord. 2007 Sep 15; 22(12):1681-8.
    View in: PubMed
    Score: 0.044
  166. Relation of cognitive activity to risk of developing Alzheimer disease. Neurology. 2007 Nov 13; 69(20):1911-20.
    View in: PubMed
    Score: 0.043
  167. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol. 2007 May; 66(5):389-98.
    View in: PubMed
    Score: 0.043
  168. Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol. 2007 Apr; 170(4):1200-9.
    View in: PubMed
    Score: 0.043
  169. Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry. 2007 Feb; 64(2):234-40.
    View in: PubMed
    Score: 0.042
  170. Parkinsonian signs and functional disability in old age. Exp Aging Res. 2007 Jan-Mar; 33(1):59-76.
    View in: PubMed
    Score: 0.042
  171. Correlates of life space in a volunteer cohort of older adults. Exp Aging Res. 2007 Jan-Mar; 33(1):77-93.
    View in: PubMed
    Score: 0.042
  172. Mild cognitive impairment. Lancet. 2006 Apr 15; 367(9518):1262-70.
    View in: PubMed
    Score: 0.040
  173. Childhood adversity and psychosocial adjustment in old age. Am J Geriatr Psychiatry. 2006 Apr; 14(4):307-15.
    View in: PubMed
    Score: 0.040
  174. Cognitive leisure activities, but not watching TV, for future brain benefits. Neurology. 2006 Mar 28; 66(6):794-5.
    View in: PubMed
    Score: 0.040
  175. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging. 2006 May; 27(5):663-72.
    View in: PubMed
    Score: 0.038
  176. Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. J Int Neuropsychol Soc. 2005 Jul; 11(4):446-53.
    View in: PubMed
    Score: 0.038
  177. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging. 2006 Feb; 27(2):252-61.
    View in: PubMed
    Score: 0.037
  178. Distress proneness and cognitive decline in a population of older persons. Psychoneuroendocrinology. 2005 Jan; 30(1):11-7.
    View in: PubMed
    Score: 0.036
  179. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging. 2004 Oct; 25(9):1197-203.
    View in: PubMed
    Score: 0.036
  180. Subregional analysis of GABA(A) receptor subunit mRNAs in the hippocampus of older persons with and without cognitive impairment. J Chem Neuroanat. 2004 Sep; 28(1-2):17-25.
    View in: PubMed
    Score: 0.036
  181. Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline. J Neurol Neurosurg Psychiatry. 2004 Aug; 75(8):1093-9.
    View in: PubMed
    Score: 0.035
  182. Blood pressure and late-life cognitive function change: a biracial longitudinal population study. Neurology. 2004 Jun 08; 62(11):2021-4.
    View in: PubMed
    Score: 0.035
  183. Decreases in soluble alpha-synuclein in frontal cortex correlate with cognitive decline in the elderly. Neurosci Lett. 2004 Apr 08; 359(1-2):104-8.
    View in: PubMed
    Score: 0.035
  184. Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci Res. 2004 Jan; 48(1):93-100.
    View in: PubMed
    Score: 0.034
  185. Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry. 2004 Jan; 75(1):126-9.
    View in: PubMed
    Score: 0.034
  186. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan; 61(1):59-66.
    View in: PubMed
    Score: 0.034
  187. Negative affect and mortality in older persons. Am J Epidemiol. 2003 Nov 01; 158(9):827-35.
    View in: PubMed
    Score: 0.034
  188. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology. 2003 Oct 28; 61(8):1102-7.
    View in: PubMed
    Score: 0.034
  189. Cognitive activity and cognitive decline in a biracial community population. Neurology. 2003 Sep 23; 61(6):812-6.
    View in: PubMed
    Score: 0.033
  190. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol. 2003 Aug; 60(8):1143-8.
    View in: PubMed
    Score: 0.033
  191. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alzheimers Dis. 2003 Feb; 5(1):39-48.
    View in: PubMed
    Score: 0.032
  192. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology. 2003 Jan 28; 60(2):246-52.
    View in: PubMed
    Score: 0.032
  193. The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry. 2002 Dec; 73(6):672-7.
    View in: PubMed
    Score: 0.032
  194. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol. 2002 Oct; 177(2):475-93.
    View in: PubMed
    Score: 0.031
  195. Association between blood pressure and cognitive function in a biracial community population of older persons. Neuroepidemiology. 2002 May-Jun; 21(3):123-30.
    View in: PubMed
    Score: 0.030
  196. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002 Feb 04; 443(2):136-53.
    View in: PubMed
    Score: 0.030
  197. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 2002 Feb; 51(2):145-55.
    View in: PubMed
    Score: 0.030
  198. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol. 2002 Feb; 51(2):182-9.
    View in: PubMed
    Score: 0.030
  199. Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment. J Histochem Cytochem. 2000 Dec; 48(12):1627-38.
    View in: PubMed
    Score: 0.027
  200. Premorbid reading activity and patterns of cognitive decline in Alzheimer disease. Arch Neurol. 2000 Dec; 57(12):1718-23.
    View in: PubMed
    Score: 0.027
  201. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 2000 Nov 06; 427(1):19-30.
    View in: PubMed
    Score: 0.027
  202. Part II. Clinical diagnosis and course of Alzheimer's disease. Dis Mon. 2000 Oct; 46(10):666-86.
    View in: PubMed
    Score: 0.027
  203. Hallucinations, delusions, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2000 Aug; 69(2):172-7.
    View in: PubMed
    Score: 0.027
  204. Progression of parkinsonism and loss of cognitive function in Alzheimer disease. Arch Neurol. 2000 Jun; 57(6):855-60.
    View in: PubMed
    Score: 0.026
  205. Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychol Aging. 2000 Mar; 15(1):18-28.
    View in: PubMed
    Score: 0.026
  206. Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. Arch Neurol. 1999 Oct; 56(10):1274-9.
    View in: PubMed
    Score: 0.025
  207. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 1999 Sep 06; 411(4):693-704.
    View in: PubMed
    Score: 0.025
  208. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 1999 Aug; 158(2):469-90.
    View in: PubMed
    Score: 0.025
  209. Word-stem completion priming in healthy aging and Alzheimer's disease: the effects of age, cognitive status, and encoding. Neuropsychology. 1999 Jan; 13(1):22-30.
    View in: PubMed
    Score: 0.024
  210. Parkinsonian signs and mortality from Alzheimer's disease. Lancet. 1998 May 30; 351(9116):1631.
    View in: PubMed
    Score: 0.023
  211. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease. Acta Neuropathol Commun. 2018 05 01; 6(1):33.
    View in: PubMed
    Score: 0.023
  212. Sensory integration deficits support a dimensional view of psychosis and are not limited to schizophrenia. Transl Psychiatry. 2017 05 09; 7(5):e1118.
    View in: PubMed
    Score: 0.021
  213. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016 09 01; 73(9):1062-9.
    View in: PubMed
    Score: 0.020
  214. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 2016 08; 12(8):882-9.
    View in: PubMed
    Score: 0.020
  215. miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet. 2015 Dec 01; 24(23):6721-35.
    View in: PubMed
    Score: 0.019
  216. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement. 2015 Sep; 11(9):1007-14.
    View in: PubMed
    Score: 0.018
  217. Alzheimer's disease: a comprehensive approach to patient management. Geriatrics. 1994 Aug; 49(8):20-6.
    View in: PubMed
    Score: 0.018
  218. White matter changes: neurobehavioral manifestations of Binswanger's disease and clinical correlates in Alzheimer's disease. Dementia. 1994 May-Aug; 5(3-4):148-52.
    View in: PubMed
    Score: 0.017
  219. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. Curr Alzheimer Res. 2013 Oct; 10(8):844-51.
    View in: PubMed
    Score: 0.017
  220. PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and A?. J Neurosci. 2013 Jun 26; 33(26):10729-40.
    View in: PubMed
    Score: 0.016
  221. AD pathology and cerebral infarctions are associated with memory and executive functioning one and five years before death. J Clin Exp Neuropsychol. 2013; 35(1):24-34.
    View in: PubMed
    Score: 0.016
  222. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study. PLoS One. 2011; 6(10):e26286.
    View in: PubMed
    Score: 0.015
  223. Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1. Alzheimers Dement. 2011 Jan; 7(1):94-109.
    View in: PubMed
    Score: 0.014
  224. Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance. J Alzheimers Dis. 2011; 24(4):767-74.
    View in: PubMed
    Score: 0.014
  225. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain. J Neurochem. 2010 Oct; 115(1):47-57.
    View in: PubMed
    Score: 0.013
  226. Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Arch Gen Psychiatry. 2010 May; 67(5):448-57.
    View in: PubMed
    Score: 0.013
  227. Identification of Caspase-6-mediated processing of the valosin containing protein (p97) in Alzheimer's disease: a novel link to dysfunction in ubiquitin proteasome system-mediated protein degradation. J Neurosci. 2010 Apr 28; 30(17):6132-42.
    View in: PubMed
    Score: 0.013
  228. Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function. Neurobiol Aging. 2010 Jul; 31(7):1089-98.
    View in: PubMed
    Score: 0.012
  229. The significance of Pin1 in the development of Alzheimer's disease. J Alzheimers Dis. 2007 Mar; 11(1):13-23.
    View in: PubMed
    Score: 0.011
  230. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4 Suppl 3):S152-69.
    View in: PubMed
    Score: 0.010
  231. Hallucinations and mortality in Alzheimer disease. Am J Geriatr Psychiatry. 2005 Nov; 13(11):984-90.
    View in: PubMed
    Score: 0.010
  232. Predictors of depressive symptoms in persons with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 2004 Mar; 59(2):P75-83.
    View in: PubMed
    Score: 0.009
  233. Premorbid proneness to distress and episodic memory impairment in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004 Feb; 75(2):191-5.
    View in: PubMed
    Score: 0.009
  234. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging. 2001 Sep-Oct; 22(5):747-54.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.